New clinical trials have increased doubts about the efficiency of Merck and Schering-Plough’s prized anti-cholesterol drug Vytorin and its ability to fight cardiovascular disease, according to medical data released here.

Originally Syndicated via RSS from Yahoo! News Search Results for vioxx